The melanoma epidemic: res ipsa loquitur.

Many have debated whether or not we are in the midst of a melanoma epidemic. Some facts are clear and helpful to this debate, while others are less clear. The incidence and mortality of melanoma have increased over the last several decades, but the incidence has risen faster than the mortality. The incidence has risen 3%-7% on average over several decades and even more rapidly among Caucasian men and the elderly. In the U.S., the incidence in men is higher than in women after the age of 40, and the difference between men and women increases from age 40 until the end of life. The incidence in the U.S. has risen most rapidly among in situ and localized lesions, but distant and regional disease have increased as well. Among localized disease, in the U.S. from 1988-1997, all stages increased by comparable amounts. This strongly argues against the idea that the increase in incidence of melanoma is only due to early detection of thin lesions or biologically benign lesions, at least during the time period studied. On the other hand, early detection of thin lesions may well account for lower increases in mortality than incidence and improvements in survival. Survival has increased from approximately 60% in the 1960s to 89% in recent years. Improvements in survival appear to be related to earlier diagnosis, rather than an improvement in survival of a given stage. Studies consistently point to a major role for UV light exposure as the most important risk factor for those individuals with a phenotypic susceptibility. Public health efforts aim at primary and secondary prevention strategies. Primary prevention strategies attempt to prevent people from developing melanoma, primarily through avoiding exposure to UV light. There is a particular emphasis on avoidance of UV light exposure in childhood and young adulthood, when it appears the risk is greatest. When strict avoidance cannot be adhered to, sunscreens have been logically recommended. Secondary prevention strategies include screening campaigns and educational campaigns. Many of these strategies appear promising but require further rigorous testing. The melanoma epidemic has arisen for a variety of reasons including: a true increase in melanomas of malignant behavior, a particularly high increase in localized and in situ lesions, and an increase in the number of biopsies performed, which may have resulted in an increased detection of less aggressive lesions. The contribution of possible changes in the diagnostic criteria for melanoma to the increased incidence remains unknown.

[1]  A. Marghoob,et al.  Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. , 1995, Journal of the American Academy of Dermatology.

[2]  J. Moan,et al.  Environmental UV Photobiology , 1993, Springer US.

[3]  W. Clark,et al.  High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. , 1985, Annals of internal medicine.

[4]  C. Begg,et al.  Screening for cutaneous melanoma by skin self-examination. , 1996, Journal of the National Cancer Institute.

[5]  G. Kok,et al.  Research to support health promotion in practice: a plea for increased co-operation , 1990 .

[6]  L. Dennis,et al.  Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. , 1999, Archives of dermatology.

[7]  S. Gruber,et al.  Is physician detection associated with thinner melanomas? , 1999, JAMA.

[8]  Daniel S. Miller,et al.  Cancer incidence and mortality, 1973‐1995 , 1998 .

[9]  Gail M. Williams,et al.  Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. , 2002, Archives of dermatology.

[10]  P. Hersey,et al.  An analysis of a melanoma epidemic , 1993, International journal of cancer.

[11]  R. Burton,et al.  Recent incidence trends imply a nonmetastasizing form of invasive melanoma , 1994, Melanoma research.

[12]  R. MacKie The pathogenesis of cutaneous malignant melanoma. , 1983, British medical journal.

[13]  R. MacKie,et al.  Audit of public education campaign to encourage earlier detection of malignant melanoma. , 1992, BMJ.

[14]  Robert C. Burton,et al.  Non‐metastasizing melanoma? , 1998, Journal of surgical oncology.

[15]  W. Willett,et al.  Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. , 1989, Pediatrics.

[16]  R. Marks,et al.  Routine retesting is necessary , 1985, BMJ.

[17]  H. Soyer,et al.  Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. , 1994, The Journal of investigative dermatology.

[18]  G. Giles,et al.  Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994 , 1996, BMJ.

[19]  A Halpern,et al.  Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. , 1997, JAMA.

[20]  Tim K. Lee,et al.  Broad-spectrum sunscreen use and the development of new nevi in white children: A randomized controlled trial. , 2000, JAMA.

[21]  A. Jemal,et al.  Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.

[22]  Suephy C. Chen,et al.  The melanoma epidemic : Is increased surveillance the solution or the problem ? , 1996 .

[23]  D. English,et al.  The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. , 1986, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[24]  Elwood Jm Melanoma and sun exposure: contrasts between intermittent and chronic exposure. , 1992 .

[25]  K. Freedberg,et al.  Screening for malignant melanoma: A cost-effectiveness analysis. , 1999, Journal of the American Academy of Dermatology.

[26]  R. Swerlick,et al.  The melanoma epidemic: more apparent than real? , 1997, Mayo Clinic proceedings.

[27]  R. Lew,et al.  Who discovers melanoma? Patterns from a population-based survey. , 1992, Journal of the American Academy of Dermatology.

[28]  D. Lipsker,et al.  Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. , 1999, Archives of dermatology.

[29]  L. Lamberg Epidemic" of malignant melanoma: true increase or better detection? , 2002 .

[30]  Donald R. Miller,et al.  Who is being screened for melanoma/skin cancer? Characteristics of persons screened in Massachusetts. , 1991, Journal of the American Academy of Dermatology.

[31]  D. Miller,et al.  Update on the incidence and mortality from melanoma in the United States. , 1999, Journal of the American Academy of Dermatology.

[32]  E. Holly,et al.  Number of melanocytic nevi as a major risk factor for malignant melanoma. , 1987, Journal of the American Academy of Dermatology.

[33]  John A. H. Lee,et al.  THE RELATIONSHIP BETWEEN MALIGNANT MELANOMA OF SKIN AND EXPOSURE TO SUNLIGHT , 1989, Photochemistry and photobiology.

[34]  Gail M. Williams,et al.  Ultraviolet Radiation and Skin Cancer: Epidemiological Data from Australia , 1993 .